Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

362 recalls · Class III, newest first

Class III · Low risk

Higher Education Make Out Ready Vegan Lip Balm

Mislabeling: The active ingredient list on the label does not match the product's actual ingredients Specifically, the label states Octinoxate 7.5% and Oxybenzone 3%, while the product therein is made with Octinoxate 7.5%, Octisalate 5%, Octocrylene 5%, and Avobenzone 3%.

Terminated Labeling / mix-up Eco Lips, Inc D-0890-2022
Class III · Low risk

23.4% Sodium Chloride Injection

Labeling: Incorrect Barcode: Product barcode incorrectly identifies the product as rocuronium bromide injection 100 mg per 10 mL instead of sodium chloride injection 23.4%, 120 mEq per 30 mL.

Terminated Labeling / mix-up The Ritedose Corporation D-0745-2022
Class III · Low risk

Cetirizine hydrochloride

Labeling: Not Elsewhere classified: Product was relabeled as 90 tablet count product although it was a manufacturer in a box with 30 tablet count tablets.

Terminated Labeling / mix-up A-S Medication Solutions LLC. D-0096-2022
Class III · Low risk

Butalbital

Labeling: Not Elsewhere Classified: the controlled substance classification "CIII" is missing on the label

Ongoing Labeling / mix-up Bryant Ranch Prepack, Inc. dba BRP Pharmaceuticals D-0257-2022
Class III · Low risk

Butalbital

Labeling: Not Elsewhere Classified: the controlled substance classification "CIII" is missing on the label

Ongoing Labeling / mix-up Bryant Ranch Prepack, Inc. dba BRP Pharmaceuticals D-0256-2022
Class III · Low risk

Levetiracetam Tablets USP

Labeling; Wrong Barcode; error in the machine-readable barcode which could result in some units being read as Naproxen Tablets 500 mg. Product is labeled correctly as Levetiracetam

Terminated Labeling / mix-up McKesson Corporation dba McKesson Drug Company NDC 63739-795-10 D-0630-2021
Class III · Low risk

Thiamine HCl Injection

Labeling: Incorrect or Missing Lot and/or Exp Date: Cartons with the correct lot number 200906 contain vials labeled with the incorrect lot number 200901.

Terminated Labeling / mix-up Mylan Institutional LLC D-0601-2021
Class III · Low risk

Acyclovir Tablets

Labeling: Incorrect or Missing Lot and/or Exp Date

Terminated Labeling / mix-up Heritage Pharmaceuticals Inc NDC 23155-227-01 D-0367-2021
Class III · Low risk

Distributed by: DocRx

Labeling: Illegible label: Manufacturer received complaint of mis-alignment print of the printed dosing instructions on the blister card.

Ongoing Labeling / mix-up Asclemed USA Inc. dba Enovachem Pharmaceuticals D-0330-2021
Class III · Low risk

Methylprednisolone Tablets USP

Labeling: Illegible label: Customer complaint received of mis-alignment print of the printed dosing instructions on the blister card.

Terminated Labeling / mix-up Jubilant Cadista Pharmaceuticals, Inc. NDC 59746-001-03 D-0298-2021
Class III · Low risk

Glycopyrrolate Injection

Labeling; Label Mix-up; correctly labeled 2 mL vials were packaged into blister strips labeled for 1 mL vials

Terminated Labeling / mix-up Accord Healthcare, Inc. NDC 16729-472-08 D-0250-2021
Class III · Low risk

Benzphetamine tablets

Labeling: Label Mix-up: Bottle labeled as Benzonatate 100 mg capsules contained Benzphetamine 50 mg tablets and a bottle labeled as Benzphetamine 50 mg tablets contained Benzonatate 100 mg capsules.

Terminated Labeling / mix-up Calvin Scott & Company, Inc. NDC 10702-0040-50 D-1123-2022

Recalls by year